Aurora Cannabis Inc. (ACB) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.40 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 68.57%. A quarter ago, it was expected that this company would post a loss of $0.18 per share when it actually produced earnings of $0.11, delivering a surprise of 161.11%.Over the last four quarters, the company has s ...

NASDAQ | TSX: ACB Your vote is important no matter how many shares you own. Please vote today. Shareholders with questions or who need assistance voting their shares should contact Aurora's strategic advisor and proxy solicitation agent, Laurel Hill Advisory Group (Toll-Free Tel: 1-877-452-7184 / International Tel: 1-416-304-0211 E-mail: [email protected]) EDMONTON, AB, July 30, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medic ...

NASDAQ | TSX: ACB EDMONTON, AB, July 29, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its first quarter 2025 on Wednesday, August 7, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the first quarter 2025 before the opening of markets that same day. Conference Cal ...

Industry Overview - The marijuana sector is characterized by high volatility, making it challenging for investors to navigate [1][2] - Despite past quick turnarounds, current trends indicate that marijuana stocks have been on the downside, but there is positive speculation about future developments in the industry [2] Key Companies Aurora Cannabis Inc. - Aurora Cannabis Inc. operates in the production, distribution, and sale of cannabis and cannabis derivative products, both in Canada and internationally [4] - The company has received expanded cultivation licenses for a facility in Germany, allowing it to cultivate additional products and cater to the growing German patient base [5] SNDL Inc. - SNDL Inc. is involved in the production, distribution, and sale of cannabis products in Canada, with operations across various segments including Liquor Retail and Cannabis Retail [7] - The company is set to announce its Q2 2024 financial results on August 2, 2024, followed by a conference call [8] Organigram Holdings Inc. - Organigram Holdings Inc. focuses on the production and sale of cannabis and cannabis-derived products in Canada [9] - The company has made a $1 million investment into Phylos to enhance its auto flower and rare cannabinoid portfolio, with plans to receive unique auto-flower seed varietals for testing by September 30, 2024 [9]

Company's Long-Standing Investment in the Region Continues with Enhanced Local Production and Domestic Cultivar Research EDMONTON, AB, July 25, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canadian-based global medical cannabis company, has been granted two licenses by the Federal Institute for Drugs and Medical Devices (BfArM) under Germany's new Medical Cannabis Act (MedCanG). Aurora's license grants the company continued domestic cultivation, wh ...

Investing in the stock market can be a highly rewarding pursuit. However, it also brings an oasis of risks. Some stocks possess significant financial and operational weaknesses that may lead to declines in their value. Here, the focus is on three such stocks considered for the list of stocks to sell. Each of these companies is a leader in its respective sectors. However, it faces adversities that could undermine its long-term stability and profitability. The first company’s profitability and growth are clos ...

Core Viewpoint - Aurora Cannabis Inc. is preparing for its annual general and special meeting of shareholders, emphasizing the importance of shareholder participation and outlining the company's progress and future goals [1][2][3]. Group 1: Meeting Details - The virtual meeting is scheduled for August 9, 2024, at 1:00 p.m. Eastern time, allowing shareholders to participate regardless of location [2]. - Shareholders will vote on critical matters for the company's growth, highlighting the company's efforts to stabilize and strengthen its balance sheet while reducing debt [2][3]. - The company reported that fiscal 2024 was its strongest year to date, indicating positive momentum in its operations [2]. Group 2: Company Strategy and Goals - The Board of Directors and management are focused on achieving positive free cash flow by the end of calendar 2024, with confidence in their team's capabilities to deliver shareholder value [3]. - The company aims to continue building value through stability and execution against its objectives, projecting a bright future for its operations [3]. Group 3: Shareholder Engagement - The Board recommends shareholders vote in favor of all director nominees and meeting resolutions, urging early voting before the deadline of August 7, 2024 [4]. - Shareholders are encouraged to read the management information circular for detailed voting instructions and meeting resolutions [4]. Group 4: Company Overview - Aurora Cannabis operates in the medical and consumer cannabis markets across Canada, Europe, Australia, and South America, with a diverse brand portfolio [6]. - The company is dedicated to high-quality cannabis products and innovation, positioning itself as a leader in the industry [6].

Here Are Top Marijuana Stocks For Cannabis Investors This JulyMarijuana stock investors are keeping watch for the next wave of momentum. With all that has taken place over the last several months, there is still a positive outlook for the future. People are starting to speculate on what is next for legal cannabis and investing in the sector. The DEA working on rescheduling and companies are trying to expand and keep up with consumer demands and establishing a dominant brand. This also puts people in place t ...

Core Viewpoint - The article discusses the potential for meme stocks to experience significant rallies, emphasizing the importance of identifying stocks with decent fundamentals that can benefit from speculative trading [1]. Group 1: Meme Stocks Overview - Meme stocks can experience rapid price increases, making it challenging to find good entry points [1]. - GameStop (GME) is highlighted as a meme stock to avoid due to its poor fundamentals and significant price drop from $62.8 to $23.7 [2]. - The focus is on identifying meme stocks that are undervalued and have the potential for a rally when bought on dips [1][2]. Group 2: Riot Platforms (RIOT) - Riot Platforms is considered undervalued with a forward P/E of 14, despite a 15% decline in stock price over the last 12 months [3]. - The company has a zero-debt balance sheet and a cash buffer of $1.3 billion, allowing for aggressive capacity expansion [3]. - Riot Platforms aims to increase its mining capacity from 12.5 EH/s to 31.5 EH/s by the end of the year, with a long-term goal of reaching 100 EH/s by 2027, potentially offering 5x to 10x returns in the next 24 to 36 months [4]. Group 3: Aurora Cannabis (ACB) - Aurora Cannabis is positioned for growth with the upcoming U.S. Presidential elections and favorable global regulations, including legalization in Germany [5]. - The company reported its sixth consecutive quarter of positive adjusted EBITDA and aims for positive free cash flow by December 2024 [6]. - Aurora Cannabis has been consolidating for nearly 12 months, indicating a potential for a breakout if business developments remain positive [5][6]. Group 4: Entera Bio (ENTX) - Entera Bio has seen a price correction from 52-week highs of $3.35 to $1.87, presenting a buying opportunity [7]. - The company focuses on oral delivery of peptides for treating conditions like osteoporosis, which affects 200 million women globally [7]. - Entera Bio has sufficient cash runway through Q3 of 2025, reducing the risk of immediate equity dilution [8].

Cannabis Investing 2024 Here Are 3 Canadian Marijuana Stocks For YouThe cannabis sector has experienced a large amount of growth over the years. From just a few legal states and global regions to now over 50% of the USA has a legal cannabis market. Yet even with all this progress the industry continues to face an uphill battle. Cannabis operators around the United States are dealing with several conflicting concerns.One is federal reform and having laws passed in favor of small batches and legend growers. T ...